Skip to main content
Journal cover image

Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.

Publication ,  Journal Article
Smith, TJ; Koumas, L; Gagnon, A; Bell, A; Sempowski, GD; Phipps, RP; Sorisky, A
Published in: The Journal of clinical endocrinology and metabolism
January 2002

Thyroid-associated ophthalmopathy, a process in which the orbital tissues become inflamed and are remodeled, occurs with a variable presentation. In some patients, eye muscle enlargement predominates. In others, the connective/adipose tissue enlargement appears the more significant problem. Orbital fibroblasts exhibit heterogeneous phenotypes in culture. Here we report that fibroblasts derived from the connective/adipose tissue depot are distinct from those investing the extraocular muscles. Connective tissue fibroblasts represent a bimodal population of cells with regard to the surface display of the glycoprotein, Thy-1. Perimysial fibroblasts in contrast express Thy-1 uniformly. In that regard, they resemble those from the skin. When subjected to a newly defined set of culture conditions, adipocyte differentiation occurs in up to 43% of the cells. All adipocytes examined failed to display Thy-1. Fibroblasts derived from perimysium and dermis uniformly do not differentiate into adipocytes when incubated under identical culture conditions. Both Thy-1(+) and Thy-1(-) connective tissue fibroblasts express the adipogenic trigger, peroxisome proliferator activator gamma, suggesting that differences in the potential for differentiation may reside with phenotypic attributes downstream from this receptor/adipogenic transcription factor. These observations enhance our understanding of orbital adipogenesis and define previously unrecognized differences between fibroblasts from the extraocular muscle and connective tissue.

Published In

The Journal of clinical endocrinology and metabolism

DOI

EISSN

1945-7197

ISSN

0021-972X

Publication Date

January 2002

Volume

87

Issue

1

Start / End Page

385 / 392

Related Subject Headings

  • Transcription Factors
  • Thy-1 Antigens
  • Thiazolidinediones
  • Thiazoles
  • Rosiglitazone
  • Receptors, Cytoplasmic and Nuclear
  • Phenotype
  • Orbit
  • Immunohistochemistry
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Smith, T. J., Koumas, L., Gagnon, A., Bell, A., Sempowski, G. D., Phipps, R. P., & Sorisky, A. (2002). Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. The Journal of Clinical Endocrinology and Metabolism, 87(1), 385–392. https://doi.org/10.1210/jcem.87.1.8164
Smith, Terry J., Laura Koumas, AnneMarie Gagnon, Andrea Bell, Gregory D. Sempowski, Richard P. Phipps, and Alexander Sorisky. “Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.The Journal of Clinical Endocrinology and Metabolism 87, no. 1 (January 2002): 385–92. https://doi.org/10.1210/jcem.87.1.8164.
Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. The Journal of clinical endocrinology and metabolism. 2002 Jan;87(1):385–92.
Smith, Terry J., et al. “Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 1, Jan. 2002, pp. 385–92. Epmc, doi:10.1210/jcem.87.1.8164.
Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, Sorisky A. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. The Journal of clinical endocrinology and metabolism. 2002 Jan;87(1):385–392.
Journal cover image

Published In

The Journal of clinical endocrinology and metabolism

DOI

EISSN

1945-7197

ISSN

0021-972X

Publication Date

January 2002

Volume

87

Issue

1

Start / End Page

385 / 392

Related Subject Headings

  • Transcription Factors
  • Thy-1 Antigens
  • Thiazolidinediones
  • Thiazoles
  • Rosiglitazone
  • Receptors, Cytoplasmic and Nuclear
  • Phenotype
  • Orbit
  • Immunohistochemistry
  • Humans